Relvar Ellipta in Serbia: price, analogs, pharmacies
Combined drug for the treatment of chronic obstructive pulmonary disease.
- Active ingredient: vilanterol, flutikazonfuroat
- Russian-market analog: Reljavar Ellipta, Breo Ellipta
- prescription (Rx)
- from 3071 RSD
- Form: powder for inhalation, divided; 22mcg + 92mcg; total 30 doza, inhaler, 1 x 30 doza
- Manufacturer: Glaxo Wellcome Production – Evreux; Glaxo Operations UK Ltd. Trading AS Glaxo Wellcome Operations; Glaxo Operations UK Ltd. Trading AS Glaxo Wellcome Operations
- ATC: R03AK10
Pharmacy availability
Community experience
last 90 days in the medicines chat: found 1 times, not found 0 times
- 09/10/2026 — found
- 15/01/2026 — found